{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T19:27:12Z","timestamp":1793129232070,"version":"4.5.0"},"reference-count":10,"publisher":"BMJ","issue":"7","license":[{"start":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T00:00:00Z","timestamp":1715904000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["203919\/Z\/16\/Z"],"award-info":[{"award-number":["203919\/Z\/16\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["203919\/Z\/16\/Z"],"award-info":[{"award-number":["203919\/Z\/16\/Z"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Thorax"],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:p>Contemporary data on the availability, cost and affordability of essential medicines for chronic respiratory diseases (CRDs) across low-income and middle-income countries (LMICs) are missing, despite most people with CRDs living in LMICs. Cross-sectional data for seven CRD medicines in pharmacies, healthcare facilities and central medicine stores were collected from 60 LMICs in 2022\u20132023. Medicines for symptomatic relief were widely available and affordable, while preventative treatments varied widely in cost, were less available and largely unaffordable. There is an urgent need to address these issues if the Sustainable Development Goal 3 is to be achieved for people with asthma by 2030.<\/jats:p>","DOI":"10.1136\/thorax-2023-221349","type":"journal-article","created":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T18:40:35Z","timestamp":1715971235000},"page":"676-679","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":32,"title":["Availability, cost and affordability of essential medicines for chronic respiratory diseases in low-income and middle-income countries: a cross-sectional study"],"prefix":"10.1136","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6091-9316","authenticated-orcid":false,"given":"Marie","family":"Stolbrink","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Obianuju B","family":"Ozoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2009-4406","authenticated-orcid":false,"given":"David M G","family":"Halpin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5636-8531","authenticated-orcid":false,"given":"Rebecca","family":"Nightingale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamilah","family":"Meghji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Plum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian William","family":"Allwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1147-5744","authenticated-orcid":false,"given":"Shamanthi","family":"Jayasooriya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Mortimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,5,17]]},"reference":[{"key":"2025012402150630000_79.7.676.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31907-3"},{"key":"2025012402150630000_79.7.676.2","unstructured":"United Nations . Sustainable development goals. Sustainable development goals publication. 2021. Available: https:\/\/sdgs.un.org\/goals [Accessed 25 Sep 2021]."},{"key":"2025012402150630000_79.7.676.3","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/S0140-6736(21)00458-X","article-title":"Improving lung health in low-income and middle-income countries: from challenges to solutions","volume":"397","author":"Meghji","year":"2021","journal-title":"Lancet"},{"key":"2025012402150630000_79.7.676.4","unstructured":"World Health Organization . World Health Organization model list of essential medicines - 22nd list. Geneva World Health Organization; 2021."},{"key":"2025012402150630000_79.7.676.5","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s40273-013-0095-9","article-title":"The availability, pricing and affordability of three essential asthma medicines in 52 low- and middle-income countries","volume":"31","author":"Babar","year":"2013","journal-title":"Pharmacoeconomics"},{"key":"2025012402150630000_79.7.676.6","doi-asserted-by":"crossref","first-page":"e1423","DOI":"10.1016\/S2214-109X(22)00330-8","article-title":"The availability, cost, and affordability of essential medicines for asthma and COPD in low-income and middle-income countries: a systematic review","volume":"10","author":"Stolbrink","year":"2022","journal-title":"Lancet Glob Health"},{"key":"2025012402150630000_79.7.676.7","unstructured":"Health Action International . Collecting evidence on medicine prices & availability [Health Action International]. 2020. Available: https:\/\/haiweb.org\/what-we-do\/price-availability-affordability\/collecting-evidence-on-medicine-prices-availability\/ [Accessed 13 Jul 2023]."},{"key":"2025012402150630000_79.7.676.8","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaip.2021.10.001","article-title":"Global initiative for asthma (GINA) strategy 2021 - executive summary and rationale for key changes","volume":"10","author":"Reddel","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2025012402150630000_79.7.676.9","unstructured":"Global Initiative for Chronic Obstructive Lung Disease . Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease [Global Initiative for Chronic Obstructive Lung Disease]. 2023. Available: goldcopd.org"},{"key":"2025012402150630000_79.7.676.10","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.5588\/ijtld.22.0270","article-title":"Improving access to affordable quality-assured inhaled medicines in low- and middle-income countries","volume":"26","author":"Stolbrink","year":"2022","journal-title":"Int J Tuberc Lung Dis"}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thorax-2023-221349","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T10:15:53Z","timestamp":1737713753000},"score":1,"resource":{"primary":{"URL":"https:\/\/thorax.bmj.com\/lookup\/doi\/10.1136\/thorax-2023-221349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,17]]},"references-count":10,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,6,14]]},"published-print":{"date-parts":[[2024,7]]}},"alternative-id":["10.1136\/thorax-2023-221349"],"URL":"https:\/\/doi.org\/10.1136\/thorax-2023-221349","relation":{},"ISSN":["0040-6376","1468-3296"],"issn-type":[{"value":"0040-6376","type":"print"},{"value":"1468-3296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,17]]}}}